CG71: Familial hypercholesterolaemia: identification and management

Zusammenfassung

Familial hypercholesterolaemia: identification and management Clinical guideline Reference number: CG71 Published: 27 August 2008 Last updated: 04 October 2019 Download guidance (PDF) Recommendations People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care . Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and

Kerninformationen

x F of the full guideline) or Dutch Lipid Clinic Network (DLCN) criteria to make a clinical diagnosis of FH in primary care settings. This should be done by a healthcare professional competent in using the criteria. [2017] 1.1.6 Refer the person to an FH specialist service for DNA testing if they me...

estimation tools, such as QRISK2 and those based on the Framingham algorithm, should not be used because people with FH are already at a high risk of premature coronary heart disease . [2008, amended 2017] 1.1.13 Inform all people who have an identified mutation diagnostic of FH that they have an un...

r all people with FH a referral to a specialist with expertise in FH for confirmation of diagnosis and initiation of cascade testing. [2008] 1.2.3 Healthcare professionals with expertise in FH should explain what is meant by cascade testing, and discuss its implications with all people with FH. [200...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen